ketamine has been researched along with Hematoma, Subdural in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Hematoma, Subdural: Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report three cases of patients with subdural hematoma (SDH) not undergoing ECoG in whom CSD was suspected to be the cause of their neurologic deficits post evacuation." | 1.62 | Ketamine for empiric treatment of cortical spreading depolarization after subdural hematoma evacuation. ( DeMatteo, C; Khazanehdari, S; Ledoux, D; Lin, A; Patel, A; Rebeiz, T; Ullman, J; Wanchoo, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wanchoo, S | 1 |
| Khazanehdari, S | 1 |
| Patel, A | 1 |
| Lin, A | 1 |
| Rebeiz, T | 1 |
| DeMatteo, C | 1 |
| Ullman, J | 1 |
| Ledoux, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Ketamine Sedation Initiated Early After Aneurysmal Subarachnoid Hemorrhage: Effect on Vasospasm, Delayed Cerebral Ischemia, and Functional Outcomes[NCT05032118] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2023-04-27 | Withdrawn (stopped due to Institution change, no IRB approval) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for ketamine and Hematoma, Subdural
| Article | Year |
|---|---|
Ketamine for empiric treatment of cortical spreading depolarization after subdural hematoma evacuation.
Topics: Aged; Aged, 80 and over; Cortical Spreading Depression; Electroencephalography; Empirical Research; | 2021 |